Avac Event

Recent Advances in Eliciting Broadly Neutralizing Antibodies (bNAbs) for HIV-1 Vaccine Development

Explores cutting-edge approaches in HIV-1 vaccine development. Experts will discuss innovative immunogen design, B cell maturation strategies, and key findings from clinical and preclinical studies. Learn how translational research is shaping the next generation of HIV vaccines.

Presented by the Global HIV Vaccine Enterprise.